Bicara Therapeutics Inc
BCAX
NASDAQ
Biotechnology
$24.28
USD
+0.65 (+2.75%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $1.82B
Volume 479.9K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
VRDN | Viridian Therapeutics Inc | $2.50B | - | +23220.3% | - | |
AGIO | Agios Pharmaceuticals Inc | $2.04B | - | +140.6% | - | |
TSHA | Taysha Gene Therapies Inc | $2.04B | - | +3.4% | - | |
STOK | Stoke Therapeutics Inc | $2.04B | - | -86.2% | - | |
ZBIO | Zenas Biopharma Inc | $2.00B | - | - | - | |
SRPT | Sarepta Therapeutics Inc | $1.94B | - | -20.4% | - | |
GENB | Generate Biomedicines Inc | $1.89B | - | - | - | |
BCAX | Bicara Therapeutics Inc | $1.82B | - | - | - | |
DMRA | Damora Therapeutics Inc | $1.82B | - | - | - | |
RXRX | Recursion Pharmaceuticals Inc | $1.76B | - | -15.1% | - | |
SNDX | Syndax Pharmaceuticals Inc | $1.74B | - | +222.7% | - |
Top Peer by Growth
Vir Biotechnology Inc
+1496.1% YoY Revenue
Best 1-Year Return
Forte Biosciences Inc
+627.1% Return